{
  "actions": [
    {
      "acted_at": "2021-10-07",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2021-10-07",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s2983-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "117",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-10-07",
  "number": "2983",
  "official_title": "A bill to provide for an accelerated approval pathway for certain drugs that are authorized to be lawfully marketed in other countries.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "s1645-117",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Accelerated Drug Approval for Prescription Therapies for Coronavirus Act",
  "sponsor": {
    "bioguide_id": "B001310",
    "district": null,
    "name": "Braun, Mike",
    "state": "IN",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-10-07",
  "subjects": [
    "Cardiovascular and respiratory health",
    "Drug safety, medical device, and laboratory regulation",
    "Emergency medical services and trauma care",
    "Health",
    "Infectious and parasitic diseases",
    "Manufacturing",
    "Marketing and advertising",
    "Medical research",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2021-10-07",
    "date": "2021-11-23T21:00:37Z",
    "text": "Accelerated Drug Approval for Prescription Therapies for Coronavirus Act or the ADAPT for COVID Act \n\nThis bill authorizes the Food and Drug Administration (FDA)to create an expedited drug approval process specifically for drugs that are currently approved for sale in certain countries (i.e., a European Economic Area member country, Australia, Canada, Israel, Japan, New Zealand, South Africa, or Switzerland) and meet certain criteria. Such criteria shall include establishing that (1) the drug is safe and effective, (2) all relevant U.S. patents or legal exclusivities have expired, and (3) the drug is intended to treat or prevent COVID-19 or another disease of epidemic potential.\n\nThe FDA must process and review an application under this bill within 180 days of submission."
  },
  "titles": [
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to provide for an accelerated approval pathway for certain drugs that are authorized to be lawfully marketed in other countries.",
      "type": "official"
    },
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "ADAPT for COVID Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Accelerated Drug Approval for Prescription Therapies for Coronavirus Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "ADAPT for COVID Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-01T23:49:18Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s2983.xml"
}